CTNM
Contineum Therapeutics, Inc.
12.50$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | -269.8% | – | |
| – | +1.2% | -40.7% | +32.3% | +25.2% | |
| – | +10.2% | +15.2% | +206.6% | +47.5% | |
| – | -1,273.1% | – | – | -213.2% | |
| – | -29.8% | +250.8% | +24.2% | -55.1% | |
| – | – | -394.0% | +6.4% | -94.7% | |
| – | – | +600.0% | -100.0% | – | |
| – | – | +200.0% | -100.0% | – | |
| – | -101.6% | – | +94.0% | +3.4% | |
| – | – | +960.4% | -35.6% | +736.2% | |
| – | – | – | -276.2% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.